NO895158L - Fremgangsmaate for fremstilling av antiretrovirale furanketoner. - Google Patents

Fremgangsmaate for fremstilling av antiretrovirale furanketoner.

Info

Publication number
NO895158L
NO895158L NO89895158A NO895158A NO895158L NO 895158 L NO895158 L NO 895158L NO 89895158 A NO89895158 A NO 89895158A NO 895158 A NO895158 A NO 895158A NO 895158 L NO895158 L NO 895158L
Authority
NO
Norway
Prior art keywords
forconsets
antiretroviral
procedure
manufacturing
antiretroviral forconsets
Prior art date
Application number
NO89895158A
Other languages
English (en)
Norwegian (no)
Other versions
NO895158D0 (no
Inventor
Roger Alan Parker
Sai Prasad Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO895158D0 publication Critical patent/NO895158D0/no
Publication of NO895158L publication Critical patent/NO895158L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
NO89895158A 1988-12-21 1989-12-20 Fremgangsmaate for fremstilling av antiretrovirale furanketoner. NO895158L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28776288A 1988-12-21 1988-12-21

Publications (2)

Publication Number Publication Date
NO895158D0 NO895158D0 (no) 1989-12-20
NO895158L true NO895158L (no) 1990-06-22

Family

ID=23104228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895158A NO895158L (no) 1988-12-21 1989-12-20 Fremgangsmaate for fremstilling av antiretrovirale furanketoner.

Country Status (15)

Country Link
EP (1) EP0374886A3 (de)
JP (1) JPH02221269A (de)
KR (1) KR900009620A (de)
CN (1) CN1043711A (de)
AU (1) AU621434B2 (de)
CA (1) CA2005991A1 (de)
DK (1) DK650089A (de)
FI (1) FI896134A7 (de)
HU (1) HUT52492A (de)
IL (1) IL92796A0 (de)
NO (1) NO895158L (de)
NZ (1) NZ231856A (de)
PH (1) PH26687A (de)
PT (1) PT92633A (de)
ZA (1) ZA899742B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA899743B (en) * 1988-12-21 1990-09-26 Merrell Dow Pharma Antiretroviral aryloxy substituted furan ketones
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
CN100395241C (zh) * 2006-05-26 2008-06-18 中国科学院南海海洋研究所 一种降解呋喃二倍半萜角质海绵素及其制备方法和应用
KR20100031528A (ko) * 2007-06-01 2010-03-22 더 트러스티즈 오브 프린스턴 유니버시티 숙주세포 대사경로의 조절을 통한 바이러스 감염 치료
ES2481346B1 (es) * 2012-12-26 2015-05-08 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención de moléculas orgánicas útiles como nuevos agentes surfactantes.
AU2021337199A1 (en) * 2020-09-03 2023-03-16 Imperial College Innovations Limited Surfactants
CN114163407B (zh) * 2020-09-11 2023-10-24 中国科学院宁波材料技术与工程研究所 抑制或杀灭微生物的呋喃环类成分、含其的制品及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1104574A (en) * 1976-12-20 1981-07-07 Roger A. Parker Antirhinovirus agents
FR2518999A1 (fr) * 1981-12-28 1983-07-01 Agrifurane Sa Procede de preparation de composes cetoniques en particulier de composes furanniques ou composes cetoniques a longues chaines, composes furanniques et composes cetoniques a longues chaines prepares par mise en oeuvre dudit procede
US4801698A (en) * 1986-08-15 1989-01-31 Warner-Lambert Company Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide
ZA899743B (en) * 1988-12-21 1990-09-26 Merrell Dow Pharma Antiretroviral aryloxy substituted furan ketones

Also Published As

Publication number Publication date
PT92633A (pt) 1990-06-29
ZA899742B (en) 1990-09-26
CA2005991A1 (en) 1990-06-21
NO895158D0 (no) 1989-12-20
DK650089A (da) 1990-06-22
AU621434B2 (en) 1992-03-12
HUT52492A (en) 1990-07-28
CN1043711A (zh) 1990-07-11
HU896706D0 (en) 1990-02-28
PH26687A (en) 1992-09-15
IL92796A0 (en) 1990-09-17
DK650089D0 (da) 1989-12-20
EP0374886A2 (de) 1990-06-27
EP0374886A3 (de) 1992-01-02
JPH02221269A (ja) 1990-09-04
FI896134A7 (fi) 1990-06-22
AU4693089A (en) 1990-06-28
FI896134A0 (fi) 1989-12-20
NZ231856A (en) 1991-05-28
KR900009620A (ko) 1990-07-05

Similar Documents

Publication Publication Date Title
NO885605D0 (no) Fremgangsmaate for fremstilling av smoereolje.
FI890719A0 (fi) Foerhindrande av nedsmutsning foerorsakad av marinorganismer.
NO880262L (no) Fremgangsmaate for fremstilling av b avermectiner.
NO885359L (no) Fremgangsmaate for fremstilling av sprengstoff.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO882295D0 (no) Fremgangsmaate for fremstilling av paryledimeren.
NO892068D0 (no) Fremgangsmaate ved fremstilling av naftatiozepinoner.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO890483L (no) Framgangsmaate for tilvirkning av formlegemer.
NO892561D0 (no) Fremgangsmaate for fremstilling av bindemidler.
NO895158D0 (no) Fremgangsmaate for fremstilling av antiretrovirale furanketoner.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO881834D0 (no) Fremgangsmaate for fremstilling av hydrokarboner.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO885200L (no) Fremgangsmaate for fremstilling av pro-legemidler.
NO893890L (no) Fremgangsmaate for fjerning av sulfider.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
NO900381D0 (no) Fremgangsmaate for fremstilling av nafthalenderivater.
NO891898D0 (no) Fremgangsmaate ved fremstilling av naftotiazepinoner.
FI892409A0 (fi) Anordning foer bildning av uppaot staoende list.
NO871721D0 (no) Fremgangsmaate for fremstilling av ergolenderivater.
NO891941D0 (no) Fremgangsmaate for fremstilling av cycloalkadiener.
NO895056D0 (no) Fremgangsmaate for fremstilling av herdeharpikser.